Cover Image
市場調查報告書

全球週邊動脈疾病 (PAD) 市場:機會分析與產業預測

Peripheral Artery Disease Market by Type - Global Opportunity Analysis and Industry Forecast, 2017-2023

出版商 Allied Market Research 商品編碼 563275
出版日期 內容資訊 英文 150 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球週邊動脈疾病 (PAD) 市場:機會分析與產業預測 Peripheral Artery Disease Market by Type - Global Opportunity Analysis and Industry Forecast, 2017-2023
出版日期: 2017年09月01日 內容資訊: 英文 150 Pages
簡介

本報告提供全球週邊動脈疾病 (PAD) 市場相關調查分析,提供市場概要,各市場區隔的市場分析,各地區分析,企業簡介等系統性資訊。

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義·範圍
  • 主要調查結果
  • 市場動態
  • 市場佔有率分析
  • 政府的法規
  • 臨床試驗

第4章 全球週邊動脈疾病 (PAD) 市場:各類型

  • 概要
  • 末梢血管成形術用氣球
  • 末梢支架
  • 血管成形術用導管
  • 下腔靜脈 (IVC) 過濾器
  • 溶菌斑修改設備
  • 血流變更設備
  • 配件

第5章 全球週邊動脈疾病 (PAD) 市場:各地區

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 南美·中東·非洲

第6章 企業簡介

  • ABBOTT LABORATORIES
  • BOSTON SCIENTIFIC CORPORATION
  • COOK
  • CARDINAL HEALTH, INC.
  • C. R. BARD, INC.
  • MEDTRONIC PLC
  • Terumo Corporation
  • SPECTRANETICS
  • ANGIODYNAMICS
  • BIOTRONIK
  • B. BRAUN MELSUNGEN AG
目錄
Product Code: LI 174315

Peripheral artery disease is characterized by plaque built up in the arteries carrying blood from heart to legs, arms, and other limbs. Peripheral artery disease in turn also increases the risk of other cardiovascular disorders such as heart attack, coronary heart disease, stroke, and ischemic attack.

The global peripheral artery disease market generated $3,136 million in 2016, and is projected to reach $4,980 million by 2023, registering a CAGR of 6.8% during the study period. The growth in geriatric population coupled with increase in incidence of peripheral artery disease are the major factors that drive the growth of the peripheral artery disease market. In addition, introduction of advanced interventional products such as drug coated balloons also boost the market growth. However, restenosis (reoccurrence of the disease post treatment) majorly restraints the market growth.

The global peripheral artery disease market is segmented on the basis of type and region. Based on type, the market is divided into peripheral angioplasty balloons, peripheral stents, peripheral catheters, inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, and peripheral accessories. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS:

  • The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors.
  • This report provides an extensive analysis of the current and emerging market trends and dynamics in the market through 2016-2023 that helps identify the upcoming market opportunities.
  • Recent industry trends and developments and the future opportunities are also covered.
  • Extensive knowledge about the key market players and their strategies is provided.
  • Comprehensive analysis of the various factors that drive and restrain the growth of the market is provided.

Key Market Segments:

By Type

  • Peripheral Angioplasty Balloons
  • Old/Normal Balloons
  • Cutting and Scoring Balloons
  • Drug-Coated Balloons
  • Peripheral Stents
  • Self-expandable
  • Balloon-expandable
  • Covered
  • Drug-eluting Stents
  • Peripheral Catheters
  • Angiography Catheters
  • Guiding Catheters
  • Inferior Vena Cava (IVC) Filters
  • Permanent Filters
  • Retrievable Filters
  • Plaque Modification Devices
  • Thrombectomy Devices
  • Mechanical Thrombectomy Devices
  • Aspiration Thrombectomy Devices
  • Rheolytic Thrombectomy Devices
  • Atherectomy Devices
  • Hemodynamic Flow Alteration Devices
  • Embolic Protection Devices
  • Chronic Total Occlusion Devices
  • Peripheral Accessories
  • Vascular Closure Devices
  • Introducer Sheaths
  • Guidewires
  • Balloon Inflation Devices

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
  • Key market players

The key players operating in this market include

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cook Medical
  • Cardinal Health, Inc.
  • C. R. Bard, Inc.
  • Medtronic plc
  • Terumo Corporation
  • The Spectranetics Corporation
  • AngioDynamics, Inc.
  • BIOTRONIK
  • B. Braun Melsungen AG

Table of Contents

CHAPTER 1 INTRODUCTION

  • 1.1. REPORT DESCRIPTION
  • 1.2. KEY BENEFITS FOR STAKEHOLDERS
  • 1.3. KEY MARKET SEGMENTS
  • 1.4. RESEARCH METHODOLOGY
    • 1.4.1. Secondary research
    • 1.4.2. Primary research
    • 1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

  • 2.1. KEY FINDINGS OF THE STUDY
  • 2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

  • 3.1. MARKET DEFINITION AND SCOPE
  • 3.2. KEY FINDINGS
    • 3.2.1. Top winning strategies
    • 3.2.2. Top investment pockets
  • 3.3. MARKET DYNAMICS
    • 3.3.1. Drivers
      • 3.3.1.1. Growing geriatric population and increasing prevalence of chronic diseases
      • 3.3.1.2. Introduction of advanced interventional products
      • 3.3.1.3. Improvement of healthcare infrastructure in developing countries
      • 3.3.1.4. Improved insurance and reimbursement
    • 3.3.2. Restraints
      • 3.3.2.1. Restenosis
      • 3.3.2.2. Stringent approval process for stents
    • 3.3.3. Opportunities
      • 3.3.3.1. Market opportunities in developing countries
    • 3.3.4. Impact analysis
  • 3.4. MARKET SHARE ANALYSIS, 2016
  • 3.5. GOVERNMENT REGULATIONS
  • 3.6. CLINICAL TRIALS

CHAPTER 4 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY TYPE

  • 4.1. OVERVIEW
    • 4.1.1. Market size and forecast
  • 4.2. PERIPHERAL ANGIOPLASTY BALLOONS
    • 4.2.1. Key market trends
    • 4.2.2. Growth factors and opportunities
    • 4.2.3. Market size and forecast
    • 4.2.4. Old/Normal Balloons
      • 4.2.4.1. Market size and forecast
    • 4.2.5. Cutting and Scoring Balloons
      • 4.2.5.1. Market size and forecast
    • 4.2.6. Drug-Coated Balloons
      • 4.2.6.1. Market size and forecast
  • 4.3. PERIPHERAL STENTS
    • 4.3.1. Key market trends
    • 4.3.2. Growth factors and opportunities
    • 4.3.3. Market size and forecast
    • 4.3.4. Self-expandable
      • 4.3.4.1. Market size and forecast
    • 4.3.5. Balloon-expandable
      • 4.3.5.1. Market size and forecast
    • 4.3.6. Covered stents
      • 4.3.6.1. Market size and forecast
    • 4.3.7. Drug-eluting Stents
      • 4.3.7.1. Market size and forecast
  • 4.4. ANGIOPLASTY CATHETERS
    • 4.4.1. Key market trends
    • 4.4.2. Growth factors and opportunities
    • 4.4.3. Market size and forecast
    • 4.4.4. Angiography Catheters
      • 4.4.4.1. Market size and forecast
    • 4.4.5. Guiding Catheters
      • 4.4.5.1. Market size and forecast
  • 4.5. INFERIOR VENA CAVA (IVC) FILTERS
    • 4.5.1. Key market trends
    • 4.5.2. Growth factors and opportunities
    • 4.5.3. Market size and forecast
    • 4.5.4. Permanent Filters
      • 4.5.4.1. Market size and forecast
    • 4.5.5. Retrievable Filters
      • 4.5.5.1. Market size and forecast
  • 4.6. PLAQUE MODIFICATION DEVICES
    • 4.6.1. Key market trends
    • 4.6.2. Growth factors and opportunities
    • 4.6.3. Market size and forecast
    • 4.6.4. Thrombectomy Devices
      • 4.6.4.1. Market size and forecast
      • 4.6.4.2. Mechanical Thrombectomy Devices
      • 4.6.4.3. Market size and forecast
      • 4.6.4.4. Aspiration Thrombectomy Devices
      • 4.6.4.5. Market size and forecast
      • 4.6.4.6. Rheolytic Thrombectomy Devices
      • 4.6.4.7. Market size and forecast
    • 4.6.5. Atherectomy Devices
      • 4.6.5.1. Market size and forecast
  • 4.7. HEMODYNAMIC FLOW ALTERATION DEVICES
    • 4.7.1. Key market trends
    • 4.7.2. Growth factors and opportunities
    • 4.7.3. Market size and forecast
    • 4.7.4. Embolic Protection Devices
      • 4.7.4.1. Market size and forecast
    • 4.7.5. Chronic Total Occlusion Devices
      • 4.7.5.1. Market size and forecast
  • 4.8. PERIPHERAL ACCESSORIES
    • 4.8.1. Key market trends
    • 4.8.2. Growth factors and opportunities
    • 4.8.3. Market size and forecast
    • 4.8.4. Peripheral vascular Closure Devices
      • 4.8.4.1. Market size and forecast
    • 4.8.5. Introducer Sheaths
      • 4.8.5.1. Market size and forecast
    • 4.8.6. Guidewires
      • 4.8.6.1. Market size and forecast
    • 4.8.7. Balloon Inflation Devices
      • 4.8.7.1. Market size and forecast

CHAPTER 5 PERIPHERAL ARTERY DISEASE MARKET, BY REGION

  • 5.1. OVERVIEW
    • 5.1.1. Market size and forecast
  • 5.2. NORTH AMERICA
    • 5.2.1. Key market trends
    • 5.2.2. Key growth factors and opportunities
    • 5.2.3. Market size and forecast
    • 5.2.4. U.S.
    • 5.2.5. Canada
    • 5.2.6. Mexico
  • 5.3. EUROPE
    • 5.3.1. Key market trends
    • 5.3.2. Key growth factors and opportunities
    • 5.3.3. Market size and forecast
    • 5.3.4. Germany
    • 5.3.5. France
    • 5.3.6. UK
    • 5.3.7. Italy
    • 5.3.8. Spain
    • 5.3.9. Rest of Europe
  • 5.4. ASIA-PACFIC
    • 5.4.1. Key market trends
    • 5.4.2. Key growth factors and opportunities
    • 5.4.3. Market size and forecast
    • 5.4.4. Japan
    • 5.4.5. China
    • 5.4.6. India
    • 5.4.7. Australia
    • 5.4.8. Rest of Asia-Pacific
  • 5.5. LAMEA
    • 5.5.1. Key market trends
    • 5.5.2. Key growth factors and opportunities
    • 5.5.3. Market size and forecast
    • 5.5.4. Brazil
    • 5.5.5. South Africa
    • 5.5.6. Saudi Arabia
    • 5.5.7. Rest of LAMEA

CHAPTER 6 COMPANY PROFILES

  • 6.1. ABBOTT LABORATORIES
    • 6.1.1. Company overview
    • 6.1.2. Operating business segments
    • 6.1.3. Business performance
    • 6.1.4. Key strategic moves and developments
  • 6.2. BOSTON SCIENTIFIC CORPORATION
    • 6.2.1. Company overview
    • 6.2.2. Operating business segments
    • 6.2.3. Business performance
    • 6.2.4. Key strategic moves and developments
  • 6.3. COOK
    • 6.3.1. Company overview
    • 6.3.2. Operating business segments
    • 6.3.3. Business performance
    • 6.3.4. Key strategic moves and developments
  • 6.4. CARDINAL HEALTH, INC.
    • 6.4.1. Company overview
    • 6.4.2. Operating business segments
    • 6.4.3. Business performance
    • 6.4.4. Key strategic moves and developments
  • 6.5. C. R. BARD, INC.
    • 6.5.1. Company overview
    • 6.5.2. Operating business segments
    • 6.5.3. Business performance
    • 6.5.4. Key strategic moves and developments
  • 6.6. MEDTRONIC PLC
    • 6.6.1. Company overview
    • 6.6.2. Operating business segments
    • 6.6.3. Business performance
    • 6.6.4. Key strategic moves and developments
  • 6.7. TERUMO CORPORATION
    • 6.7.1. Company overview
    • 6.7.2. Operating business segments
    • 6.7.3. Business performance
    • 6.7.4. Key strategic moves and developments
  • 6.8. SPECTRANETICS
    • 6.8.1. Company overview
    • 6.8.2. Operating business segments
    • 6.8.3. Business performance
    • 6.8.4. Key strategic moves and developments
  • 6.9. ANGIODYNAMICS
    • 6.9.1. Company overview
    • 6.9.2. Operating business segments
    • 6.9.3. Business performance
    • 6.9.4. Key strategic moves and developments
  • 6.10. BIOTRONIK
    • 6.10.1. Company overview
    • 6.10.2. Operating business segments
    • 6.10.3. Business performance
    • 6.10.4. Key strategic moves and developments
  • 6.11. B. BRAUN MELSUNGEN AG
    • 6.11.1. Company overview
    • 6.11.2. Operating business segments
    • 6.11.3. Business performance
    • 6.11.4. Key strategic moves and developments
Back to Top